The Newest, Undiscovered CAR-T Play with a Rock-Star Partner Portfolio & Significant Near-Term Upside Potential – Baystreet.ca
|
The Newest, Undiscovered CAR–T Play with a Rock-Star Partner Portfolio & Significant Near-Term Upside Potential
Baystreet.ca Newly NASDAQ-listed cell therapy manufacturer Orgenesis (ORGS) growing revenue in mega-blockbuster cell therapy industry. Company executing well (sales +58% last year) with high-profile partnerships, like CRISPR Therapeutics (CRSP) and Servier. Company … |
